Posted in | News | Mining Business

Governments Announce Support for Alcoa’s Gallium Critical Mineral Development Project in Western Australia

Alcoa Corporation (“Alcoa”) welcomes the announcement of the United States and Australian governments to advance the development of a gallium plant to be co-located at the Company’s Wagerup alumina refinery in Western Australia.

This latest development follows support given for the project from Japan Australia Gallium Associates Pty Ltd (“JAGA”), a joint venture between the Japanese Government and Sojitz Corporation (“Sojitz”), through a Joint Development Agreement (“JDA”) with Alcoa announced in August 2025. Following completion of feasibility assessments, Alcoa expects that a joint U.S., Australia and Alcoa special purpose vehicle (“SPV”) would enter into the joint venture with JAGA to construct a gallium plant. The plant, which would be operated by Alcoa, would be expected to produce 100 metric tons of gallium annually. Today’s announcement confirms support for the gallium joint venture.

Under the terms of the non-binding agreement, the U.S. and Australian governments and Alcoa would provide capital to the SPV and receive gallium offtake in proportion to their interests. Among other purposes, the capital would be used for preparation of final feasibility studies, and the development and construction of the project. Definitive agreements for the gallium joint venture will be prepared among the governments of the United States, Australia and Japan, and Alcoa and Sojitz.

Gallium is naturally present in bauxite, the raw material used in the production of alumina, and can be extracted during the refining process. Gallium is a critical mineral essential to technology, especially the semiconductor industry and defense sectors and is recognized as vital to national security by the United States, Australia and Japan. Globally, gallium production is concentrated from a single source, and market controls have heightened interest in establishing and securing alternate supply chains.

“Alcoa has been a strong contributor to both the American and Australian economies and welcomes the opportunity to support both nations in progressing a new source of gallium,” said Alcoa President and CEO William F. Oplinger. “The investment support from the U.S. and Australian governments underscores Alcoa’s role in supporting the development of the critical mineral supply chain, and the importance of our Australian operations not only to the aluminum industry, but also as key to manufacturing, technology, and defense industries.”

Alcoa will continue to work cooperatively with the Western Australian Government to progress the project under the State Agreement and approvals framework. The parties are targeting 2026 for final investment decision and production.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Alcoa Corporation. (2025, October 22). Governments Announce Support for Alcoa’s Gallium Critical Mineral Development Project in Western Australia. AZoMining. Retrieved on October 22, 2025 from https://www.azomining.com/News.aspx?newsID=18481.

  • MLA

    Alcoa Corporation. "Governments Announce Support for Alcoa’s Gallium Critical Mineral Development Project in Western Australia". AZoMining. 22 October 2025. <https://www.azomining.com/News.aspx?newsID=18481>.

  • Chicago

    Alcoa Corporation. "Governments Announce Support for Alcoa’s Gallium Critical Mineral Development Project in Western Australia". AZoMining. https://www.azomining.com/News.aspx?newsID=18481. (accessed October 22, 2025).

  • Harvard

    Alcoa Corporation. 2025. Governments Announce Support for Alcoa’s Gallium Critical Mineral Development Project in Western Australia. AZoMining, viewed 22 October 2025, https://www.azomining.com/News.aspx?newsID=18481.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.